Insider Transactions in Q1 2024 at Bioventus Inc. (BVS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2024
|
Mark Leonard Singleton SVP & CFO |
SELL
Open market or private sale
|
Direct |
5,541
-17.76%
|
$27,705
$5.39 P/Share
|
|
Mar 21
2024
|
Mark Leonard Singleton SVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,625
+37.38%
|
-
|
|
Mar 15
2024
|
Katrina J Church SVP & Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
1,217
-7.96%
|
$6,085
$5.46 P/Share
|
|
Mar 15
2024
|
Anthony D'Adamio SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,125
-5.73%
|
$15,625
$5.46 P/Share
|
|
Mar 14
2024
|
Katrina J Church SVP & Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,456
+18.44%
|
-
|
|
Mar 14
2024
|
Anthony D'Adamio SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,886
+14.02%
|
-
|